What are the early symptoms of nasopharyngeal carcinoma bone metastasis

What are the early symptoms of nasopharyngeal carcinoma bone metastasis?

1. Nasopharyngeal carcinoma refers to a malignant tumor that occurs in the nasopharyngeal mucosa. Pain occurs after the cancer metastasizes to the bones, causing other symptoms that make the patient even more miserable. The most common sites of nasopharyngeal carcinoma bone metastasis are the spine, pelvis and ribs, followed by the scapula, humerus, femur, skull, etc. Most cases are multiple bone metastases throughout the body, and single metastasis is rare.

2. There are no symptoms in the early stage of nasopharyngeal carcinoma bone metastasis. When the tumor grows to a certain size, it will compress or stimulate the sensory nerve endings, or cause bone destruction and pain. The pain is intermittent at first, and then becomes continuous, especially at night, and cannot be relieved by rest or immobilization. The pain is significantly aggravated when pressing the bone metastasis. Local patients are accompanied by low fever or anemia. Pathological fractures may occur in patients with severe bone skin necrosis. If it is a cervical fracture, it can compress the cervical spinal cord, causing weakness in the limbs, difficulty breathing, and even respiratory arrest. Cachexia may occur in the late stage.

3. The difficulty of treating nasopharyngeal carcinoma will increase a lot after bone metastasis of nasopharyngeal carcinoma. Some experts pointed out that the Chinese medicine ginsenoside Rh2 reduces the possibility of bone metastasis of nasopharyngeal carcinoma. Ginsenoside Rh2 is an active anti-cancer substance in ginseng. Its content is quite rare and it is a rare saponin. Tumor metastasis is mainly caused by the formation of tumor blood vessels and tumor lymphatic vessels, and ginsenoside Rh2 can inhibit the formation of tumor blood vessels and lymphatic vessels to prevent the occurrence of metastasis. Many patients took ginsenoside Rh2 at the same time as radiotherapy and obtained very significant clinical results, which reduced the metastasis rate of nasopharyngeal carcinoma by at least 30%. It is worth mentioning that ginsenoside Rh2 can also reduce symptoms such as pain and weakness during bone metastasis.